Helen of Troy Limited (NASDAQ:HELE – Get Free Report) has received an average rating of “Hold” from the five analysts that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $26.50.
A number of research firms have recently commented on HELE. Wall Street Zen raised Helen of Troy from a “hold” rating to a “strong-buy” rating in a research note on Sunday, July 12th. Weiss Ratings lowered Helen of Troy from a “sell (d)” rating to a “sell (d-)” rating in a research note on Tuesday, July 21st. Canaccord Genuity Group boosted their price objective on Helen of Troy from $23.00 to $25.00 and gave the company a “hold” rating in a report on Thursday, July 9th. UBS Group upped their price objective on Helen of Troy from $25.00 to $28.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. Finally, Zacks Research lowered Helen of Troy from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th.
Read Our Latest Report on HELE
Institutional Inflows and Outflows
Helen of Troy Stock Performance
Shares of NASDAQ:HELE opened at $29.06 on Friday. The company has a market capitalization of $676.81 million, a price-to-earnings ratio of -1.62 and a beta of 1.31. Helen of Troy has a 12 month low of $13.85 and a 12 month high of $30.68. The firm’s 50-day moving average is $28.12 and its 200 day moving average is $22.83. The company has a current ratio of 1.78, a quick ratio of 0.81 and a debt-to-equity ratio of 0.82.
Helen of Troy (NASDAQ:HELE – Get Free Report) last posted its quarterly earnings data on Wednesday, July 8th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.15. The company had revenue of $402.12 million for the quarter, compared to analyst estimates of $374.55 million. Helen of Troy had a negative net margin of 22.70% and a positive return on equity of 6.46%. The firm’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.41 EPS. Helen of Troy has set its FY 2027 guidance at 3.250-3.750 EPS. Research analysts predict that Helen of Troy will post 2.84 EPS for the current year.
Helen of Troy Company Profile
Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.
The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.
Featured Stories
- Five stocks we like better than Helen of Troy
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for Helen of Troy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helen of Troy and related companies with MarketBeat.com's FREE daily email newsletter.
